Columbia Tech Ventures

Venture Capital Perspectives: Early Stage Biotech Investing


Listen Later

Presenting a discussion and Q&A with Doug Cole, managing partner of Flagship Ventures, a life science venture fund with over $1.4 billion under management and a new $574 million fund devoted to early-stage therapeutics, health technologies and sustainability. In an interview with CTV’s Executive Director Orin Herskowitz, Doug discusses Flagship Ventures’ perspective on opportunities and challenges within the venture investment landscape, current trends, past experiences with early-stage investing, its VentureLabs Fellows program, and building a career as a venture capitalist.
...more
View all episodesView all episodes
Download on the App Store

Columbia Tech VenturesBy Columbia Technology Ventures